Williams Lewis T 4
4 · Neoleukin Therapeutics, Inc. · Filed Oct 15, 2019
Insider Transaction Report
Form 4
Williams Lewis T
Director
Transactions
- Award
Stock Option (right to buy)
2019-10-10+22,000→ 22,000 totalExercise: $2.82Exp: 2029-10-09→ Common Stock (22,000 underlying)
Footnotes (1)
- [F1]The options will vest as to 1/3 of the total number of shares underlying the options on each of October 10, 2020, October 10, 2021 and October 10, 2022, subject to the Reporting Person's provision of service to the Issuer on each vesting date.